EDP Sciences logo
Subscriber Authentication Point
Rechercher
Menu
Accueil Tous les numéros Volume 41 / Numéro 11 (Novembre 2025) Med Sci (Paris), 41 11 (2025) 877-886 References
Open Access
Issue
Med Sci (Paris)
Volume 41, Number 11, Novembre 2025
Page(s) 877 - 886
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2025187
Published online 12 décembre 2025
  1. Vijg J, Dong X. Pathogenic Mechanisms of somatic mutation and genome mosaicism in aging. Cell 2020; 182 : 12–23. [Google Scholar]
  2. Yoshida M, Tanase-Nakao K, Shima H, et al. Prevalence of germline GATA2 and SAMD9/9L variants in paediatric haematological disorders with monosomy 7. Br J Haematol 2020; 191 : 835–43. [Google Scholar]
  3. Moore L, Cagan A, Coorens THH, et al. The mutational landscape of human somatic and germline cells. Nature 2021; 597 : 381–6. [Google Scholar]
  4. Machado HE, Obro NF, Williams N, et al. Convergent somatic evolution commences in utero in a germline ribosomopathy. Nat Commun 2023; 14 : 5092. [Google Scholar]
  5. Abascal F, Harvey LMR, Mitchell E, et al. Somatic mutation landscapes at single-molecule resolution. Nature 2021; 593 : 405–10. [Google Scholar]
  6. Blokzijl F, de Ligt J, Jager M, et al. Tissue-specific mutation accumulation in human adult stem cells during life. Nature 2016; 538 : 260–4. [Google Scholar]
  7. Jacobs KB, Yeager M, Zhou W, et al. Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet 2012; 44 : 651–8. [Google Scholar]
  8. Laurie CC, Laurie CA, Rice K, et al. Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet 2012; 44 : 642–50. [Google Scholar]
  9. Lee-Six H, Obro NF, Shepherd MS, et al. Population dynamics of normal human blood inferred from somatic mutations. Nature 2018; 561 : 473–8. [Google Scholar]
  10. Osorio FG, Rosendahl Huber A, Oka R, et al. Somatic Mutations reveal lineage relationships and age-related mutagenesis in human hematopoiesis. Cell Rep 2018; 25 : 2308–16 e4. [Google Scholar]
  11. Forterre P. Darwin’s goldmine is still open: variation and selection run the world. Front Cell Infect Microbiol 2012; 2 : 106. [Google Scholar]
  12. Revy P, Kannengiesser C, Fischer A. Somatic genetic rescue in Mendelian haematopoietic diseases. Nat Rev Genet 2019; 20 : 582–98. [Google Scholar]
  13. Mitchell E, Spencer Chapman M, Williams N, et al. Clonal dynamics of haematopoiesis across the human lifespan. Nature 2022; 606 : 343–50. [Google Scholar]
  14. Gutierrez-Rodrigues F, Groarke EM, Thongon N, et al. Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescuing and cancer mutations. Blood 2024 ; 144 : 2402–16. [Google Scholar]
  15. Le Guen T, Touzot F, Andre-Schmutz I, et al. An in vivo genetic reversion highlights the crucial role of Myb-Like, SWIRM, and MPN domains 1 (MYSM1) in human hematopoiesis and lymphocyte differentiation. J Allergy Clin Immunol 2015; 136 : 1619–26. [Google Scholar]
  16. Catto LFB, Borges G, Pinto AL, et al. Somatic genetic rescue in hematopoietic cells in GATA2 deficiency. Blood 2020; 136 : 1002–5. [Google Scholar]
  17. Sahoo SS, Pastor VB, Goodings C, et al. Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes. Nat Med 2021; 27 : 1806–17. [Google Scholar]
  18. Bluteau O, Sebert M, Leblanc T, et al. A landscape of germ line mutations in a cohort of inherited bone marrow failure patients. Blood 2018; 131 : 717–32. [Google Scholar]
  19. Buonocore F, Kuhnen P, Suntharalingham JP, et al. Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans. J Clin Invest 2017; 127 : 1700–13. [Google Scholar]
  20. Shima H, Koehler K, Nomura Y, et al. Two patients with MIRAGE syndrome lacking haematological features: role of somatic second-site reversion SAMD9 mutations. J Med Genet 2018; 55 : 81–5. [Google Scholar]
  21. Tesi B, Davidsson J, Voss M, et al. Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms. Blood 2017; 129 : 2266–79. [Google Scholar]
  22. Revy P, Kannengiesser C, Bertuch AA. Genetics of human telomere biology disorders. Nature Rev Genet 2023; 24 : 86–108. [Google Scholar]
  23. Hoareau-Aveilla C, Henry Y, Leblanc T. Dyskératose congénitale, une maladie causée par une maintenance défectueuse des télomères. Med Sci (Paris) 2008; 24 : 390–8. [Google Scholar]
  24. Hennion N, Desseyn JL, Gottrand F, et al. Fibrose pulmonaire idiopathique. Med Sci (Paris) 2022; 38 : 579–84. [Google Scholar]
  25. Gutierrez-Rodrigues F, Donaires FS, Pinto A, et al. Pathogenic TERT promoter variants in telomere diseases. Genet Med 2019; 21 : 1594–602. [Google Scholar]
  26. Maryoung L, Yue Y, Young A, et al. Somatic mutations in telomerase promoter counterbalance germline loss-of-function mutations. J Clin Invest 2017; 127 : 982–6. [Google Scholar]
  27. Benyelles M, O’Donohue MF, Kermasson L, et al. NHP2 deficiency impairs rRNA biogenesis and causes pulmonary fibrosis and Hoyeraal-Hreidarsson syndrome. Hum Mol Genet 2020; 29 : 907–22. [Google Scholar]
  28. Bertrand A, Ba I, Kermasson L, et al. Characterization of novel mutations in the TEL-patch domain of the telomeric factor TPP1 associated with telomere biology disorders. Hum Mol Genet 2024; 20 : 612–23. [Google Scholar]
  29. Ellis NA, Ciocci S, German J. Back mutation can produce phenotype reversion in Bloom syndrome somatic cells. Hum Genet 2001; 108 : 167–73. [Google Scholar]
  30. Alder JK, Stanley SE, Wagner CL, et al. Exome sequencing identifies mutant TINF2 in a family with pulmonary fibrosis. Chest 2015; 147 : 1361–8. [Google Scholar]
  31. Wada T, Schurman SH, Otsu M, et al. Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc Nat Acad Sci USA 2001; 98 : 8697–702. [Google Scholar]
  32. Cunniff C, Bassetti JA, Ellis NA. Bloom’s Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition. Mol Syndromol 2017; 8 : 4–23. [Google Scholar]
  33. Venugopal P, Arts P, Fox LC, et al. Unraveling facets of MECOM-associated syndrome: somatic genetic rescue, clonal hematopoiesis, and phenotype expansion. Blood Adv 2024; 8 : 3437–43. [Google Scholar]
  34. Wong JC, Bryant V, Lamprecht T, et al. Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes. JCI Insight 2018; 3 : e121086. [Google Scholar]
  35. Sharma R, Sahoo SS, Honda M, et al. Gain-of-function mutations in RPA1 cause a syndrome with short telomeres and somatic genetic rescue. Blood 2022; 139 : 1039–51. [Google Scholar]
  36. Jongmans MCJ, Diets IJ, Quarello P, et al. Somatic reversion events point towards RPL4 as a novel disease gene in a condition resembling Diamond-Blackfan Anemia. Haematologica 2018; 103 : e607–9. [Google Scholar]
  37. Jongmans MC, Verwiel ET, Heijdra Y, et al. Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita. Am J Hum Genet 2012; 90 : 426–33. [Google Scholar]
  38. Garelli E, Quarello P, Giorgio E, et al. Spontaneous remission in a Diamond-Blackfan anaemia patient due to a revertant uniparental disomy ablating a de novo RPS19 mutation. Brit J Haematol 2019; 185 : 994–8. [Google Scholar]
  39. Sahoo SS, Erlacher M, Wlodarski MW. Genetic and clinical spectrum of SAMD9 and SAMD9L syndromes: from variant interpretation to patient management. Blood 2025; 145 : 475–85. [Google Scholar]
  40. Pellestor F, Gatinois V, Puechberty J, et al. La chromothripsis, une nouvelle forme inattendue de complexité pour les réarrangements chromosomiques. Med Sci (Paris) 2014; 30 : 266–73. [Google Scholar]
  41. McDermott DH, Gao JL, Liu Q, et al. Chromothriptic cure of WHIM syndrome. Cell 2015; 160 : 686–99. [Google Scholar]
  42. Warren AJ. Molecular basis of the human ribosomopathy Shwachman-Diamond syndrome. Adv Biol Regul 2017; S2212-4926 : 30153–7. [Google Scholar]
  43. Pressato B, Valli R, Marletta C, et al. Deletion of chromosome 20 in bone marrow of patients with Shwachman-Diamond syndrome, loss of the EIF6 gene and benign prognosis. Brit J Haematol 2012; 157 : 503–5. [Google Scholar]
  44. Valli R, Minelli A, Galbiati M, et al. Shwachman-Diamond syndrome with clonal interstitial deletion of the long arm of chromosome 20 in bone marrow: haematological features, prognosis and genomic instability. Brit J Haematol 2019; 184 : 974–81. [Google Scholar]
  45. Valli R, Pressato B, Marletta C, et al. Different loss of material in recurrent chromosome 20 interstitial deletions in Shwachman-Diamond syndrome and in myeloid neoplasms. Mol Cytogenet 2013; 6 : 56. [Google Scholar]
  46. Tan S, Kermasson L, Hilcenko C, et al. Somatic genetic rescue of a germline ribosome assembly defect. Nat Commun 2021; 12 : 5044. [Google Scholar]
  47. Kennedy AL, Myers KC, Bowman J, et al. Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome. Nat Commun 2021; 12 : 1334. [Google Scholar]
  48. Schratz KE, Gaysinskaya V, Cosner ZL, et al. Somatic reversion impacts evolution of myelodysplastic syndromes and acute myeloid leukemia in the short telomere disorders. J Clin Invest 2021 ; 131 : e147598. [Google Scholar]
  49. Kochman R, Ba I, Yates M, et al. Heterozygous RPA2 variant as a novel genetic cause of telomere biology disorders. Genes Dev 2024; 38 : 755–71. [Google Scholar]
  50. Sande CM, Chen S, Mitchell DV, et al. ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disorders. J Clin Invest 2025; 135. [Google Scholar]
  51. de Tocqueville S, Martin E, Riller Q, et al. Long-term assessment of haematological recovery following somatic genetic rescue in a MYSM1-deficient patient: Implications for in vivo gene therapy. Brit J Haematol 2024; 205 : 2349–54. [Google Scholar]
  52. Notarangelo LD, Kim MS, Walter JE, Lee YN. Human RAG mutations: biochemistry and clinical implications. Nat Rev Immunol 2016; 16 : 234–46. [Google Scholar]
  53. Davidsson J, Puschmann A, Tedgard U, et al. SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies. Leukemia 2018; 32 : 1106–15. [Google Scholar]
  54. Pesce E, Miluzio A, Turcano L, et al. discovery and preliminary characterization of translational modulators that impair the binding of eIF6 to 60S ribosomal subunits. Cells 2020; 9 : 172. [Google Scholar]
  55. Shipman AR, Liu L, Lai-Cheong JE, et al. Somatic forward (nonrevertant) mosaicism in recessive dystrophic epidermolysis bullosa. JAMA Dermatol 2014; 150 : 1025–7. [Google Scholar]
  56. Lim YH, Fisher JM, Choate KA. Revertant mosaicism in genodermatoses. Cell Mol Life Sci 2017; 74 : 2229–38. [Google Scholar]
  57. Burrow KL, Coovert DD, Klein CJ, et al. Dystrophin expression and somatic reversion in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group. Neurology 1991; 41 : 661–6. [Google Scholar]
  58. Fanin M, Danieli GA, Cadaldini M, et al. Dystrophin-positive fibers in Duchenne dystrophy: origin and correlation to clinical course. Muscle Nerve 1995; 18 : 1115–20. [Google Scholar]
  59. Klein CJ, Coovert DD, Bulman DE, et al. Somatic reversion/suppression in Duchenne muscular dystrophy (DMD): evidence supporting a frame-restoring mechanism in rare dystrophin-positive fibers. Am J Hum Genet 1992; 50 : 950–9. [Google Scholar]
  60. Punetha J, Mansoor S, Bertorini TE, et al. Somatic mosaicism due to a reversion variant causing hemi-atrophy: a novel variant of dystrophinopathy. Eur J Hum Genet 2016; 24 : 1511–4. [Google Scholar]
  61. Brzozowska N, Wu LYD, Khodzhaeva V, et al. Selection for somatic escape variants in SERPINA1 in the liver of patients with alpha-1 antitrypsin deficiency. Nat Genet 2025; 57 : 875–83. [Google Scholar]
  62. Stewart O, Gruber C, Randolph HE, et al. Monoallelic expression can govern penetrance of inborn errors of immunity. Nature 2025; 637 : 1186–97. [Google Scholar]
  63. Gilgenkrantz H. Trans… Med Sci (Paris) 2024 ; 40 : 555. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.